13D/13G Filings - Theseus Pharmaceuticals Inc. (THRX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-10-19
5:23 pm
Purchase
2021-10-1213DTheseus Pharmaceuticals, Inc.
THRX
ORBIMED ADVISORS LLC16,838,668
44.900%
16,838,668increase
(New Position)
Filing
History
2021-10-18
1:15 pm
Purchase
2021-10-0713DTheseus Pharmaceuticals, Inc.
THRX
Foresite Capital Fund V L.P.3,681,552
9.800%
3,681,552increase
(New Position)
Filing
History
Goto Prev, 0, 1